Lung Cancer Somatic Panel (30 Genes)
Definition
While the NCCN guideline recommends that EGFR, ALK, ROS1 and PD-L1 be tested at a minimum in NSCLC, the broader molecular profiling approach also requires evaluation of BRAF, ERBB2, KRAS, METex14 and NTRK1/2/3 and RET rearrangements. NGS panels make it possible to evaluate all of these genes at once.
Gene/region examined
FGFR2, BRAF, KRAS, NRAS, MET, CDK6, EGFR, SOD2, ESR1, ROS1, RICTOR, TERT, KIT, PDGFRA, PIK3CA, MYD88, ERBB4, IDH1, IDH2, ALK, STK11, ERBB2, TP53, MAP2K1, AKT1, CDK4, GAPDH, PTEN, DDR2, NTRK1
Method
Next Generation Sequencing
Accepted sample types
Solid Tumor-FFPE
Inheritance
Entirely somatic (acquired in tumor tissue) mutation and fusion analysis; germline tissue is not evaluated.